Literature DB >> 20148283

Urinary trypsin inhibitor suppresses excessive generation of superoxide anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats.

Ryo Tanaka1, Motoki Fujita, Ryosuke Tsuruta, Kenji Fujimoto, Hiromi Shinagawa Aki, Kazumi Kumagai, Tetsuya Aoki, Akihiro Kobayashi, Tomonori Izumi, Shunji Kasaoka, Makoto Yuasa, Tsuyoshi Maekawa.   

Abstract

OBJECTIVE AND
DESIGN: The protective effects of ulinastatin, a human urinary trypsin inhibitor (UTI), against superoxide radical (O(2)(-*)) generation, systemic inflammation, lipid peroxidation, and endothelial injury were investigated in endotoxemic rats. MATERIALS AND TREATMENT: Twenty-one Wistar rats were allocated to a control group, a UTI group, and a sham group. A bolus of lipopolysaccharide (LPS; 3 microg/g) was administered intravenously to the control group, a bolus of LPS and UTI (5 U/g) to the UTI group, and a bolus of saline to the sham group.
METHODS: The O(2)(-*) generated was measured as the current in the right atrium using an electrochemical O(2)(-*) sensor. Plasma nitrite, high mobility group box 1 (HMGB1), tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, malondialdehyde, and soluble intercellular adhesion molecule-1 (sICAM-1) were measured 360 min after LPS administration.
RESULTS: The O(2)(-*) current increased in the control group and was significantly attenuated in the UTI group after 55 min (P < 0.05 at 55-60 min, P < 0.01 at 65-360 min). Plasma nitrite, HMGB1, TNF-alpha, IL-6, malondialdehyde, and sICAM-1 were attenuated in the UTI group.
CONCLUSIONS: UTI suppressed excessive O(2)(-*) generation, systemic inflammation, lipid peroxidation, and endothelial injury in endotoxemic rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148283     DOI: 10.1007/s00011-010-0166-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  44 in total

Review 1.  Activators and target genes of Rel/NF-kappaB transcription factors.

Authors:  H L Pahl
Journal:  Oncogene       Date:  1999-11-22       Impact factor: 9.867

2.  Human urinary trypsin inhibitor (urinastatin)-like substance in mouse kidney and its relationships to mouse kidney kallikrein.

Authors:  T Shikimi; S Suzuki
Journal:  Biol Chem Hoppe Seyler       Date:  1990-10

Review 3.  Neutrophils and acute lung injury.

Authors:  Edward Abraham
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

4.  In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation.

Authors:  T S Blackwell; T R Blackwell; E P Holden; B W Christman; J W Christman
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

5.  Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-alpha production through inhibition of Egr-1 expression.

Authors:  Perenlei Molor-Erdene; Kenji Okajima; Hirotaka Isobe; Mitsuhiro Uchiba; Naoaki Harada; Hiroaki Okabe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11-11       Impact factor: 4.733

6.  Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide.

Authors:  Ken-Ichiro Inoue; Hirohisa Takano; Akinori Shimada; Rie Yanagisawa; Miho Sakurai; Shin Yoshino; Hiroyuki Sato; Toshikazu Yoshikawa
Journal:  Mol Pharmacol       Date:  2004-12-02       Impact factor: 4.436

7.  Protective effect of ulinastatin against liver injury caused by ischemia-reperfusion in rats.

Authors:  Y Kudo; T Egashira; Y Yamanaka
Journal:  Jpn J Pharmacol       Date:  1992-11

8.  Polyethylene glycol-superoxide dismutase prevents endotoxin-induced cardiac dysfunction.

Authors:  Gerald S Supinski; Leigh A Callahan
Journal:  Am J Respir Crit Care Med       Date:  2006-03-02       Impact factor: 21.405

9.  Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress.

Authors:  J Scott McNally; Michael E Davis; Don P Giddens; Aniket Saha; Jinah Hwang; Sergey Dikalov; Hanjoong Jo; David G Harrison
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-09-04       Impact factor: 4.733

10.  HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling.

Authors:  Allan Tsung; John R Klune; Xianghong Zhang; Geetha Jeyabalan; Zongxian Cao; Ximei Peng; Donna B Stolz; David A Geller; Matthew R Rosengart; Timothy R Billiar
Journal:  J Exp Med       Date:  2007-11-05       Impact factor: 14.307

View more
  16 in total

1.  Effects of ulinastatin on early postoperative cognitive function after one-lung ventilation surgery in elderly patients receiving neoadjuvant chemotherapy.

Authors:  Kai-Yuan Wang; Quan-Yong Yang; Peng Tang; Hui-Xia Li; Hong-Wei Zhao; Xiu-Bao Ren
Journal:  Metab Brain Dis       Date:  2016-11-09       Impact factor: 3.584

Review 2.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

3.  Ulinastatin activates haem oxygenase 1 antioxidant pathway and attenuates allergic inflammation.

Authors:  Dongmei Song; Geng Song; Yinghao Niu; Wei Song; Jiantao Wang; Lei Yu; Jianwang Yang; Xin Lv; Harry Steinberg; Shu Fang Liu; Baoshan Wang
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

4.  Polymorphisms in the myeloperoxidase gene locus are associated with acute kidney injury-related outcomes.

Authors:  Mary C Perianayagam; Hocine Tighiouart; Orfeas Liangos; Diana Kouznetsov; Ron Wald; Fangwen Rao; Daniel T O'Connor; Bertrand L Jaber
Journal:  Kidney Int       Date:  2012-06-27       Impact factor: 10.612

5.  CYBA Gene Polymorphisms and Adverse Outcomes in Acute Kidney Injury: A Prospective Cohort Study.

Authors:  Mary C Perianayagam; Hocine Tighiouart; Caroline M Nievergelt; Daniel T O'Connor; Orfeas Liangos; Bertrand L Jaber
Journal:  Nephron Extra       Date:  2011-10-21

6.  Postconditioning improvement effects of ulinastatin on brain injury following cardiopulmonary resuscitation.

Authors:  Bo Sui; Yongwang Li; Li Ma
Journal:  Exp Ther Med       Date:  2014-08-04       Impact factor: 2.447

7.  Ulinastatin suppresses burn-induced lipid peroxidation and reduces fluid requirements in a Swine model.

Authors:  Hong-Min Luo; Ming-Hua Du; Zhi-Long Lin; Quan Hu; Lin Zhang; Li Ma; Huan Wang; Yu Wen; Yi Lv; Hong-Yuan Lin; Yu-Li Pi; Sen Hu; Zhi-Yong Sheng
Journal:  Oxid Med Cell Longev       Date:  2013-04-24       Impact factor: 6.543

8.  Ulinastatin preconditioning attenuates inflammatory reaction of hepatic ischemia reperfusion injury in rats via high mobility group box 1(HMGB1) inhibition.

Authors:  Ying Tong; Zhaohui Tang; Tian Yang; Yuting Yang; Liqun Yang; Weixing Shen; Weixin Chen
Journal:  Int J Med Sci       Date:  2014-02-11       Impact factor: 3.738

9.  Intravenous administration of ulinastatin (human urinary trypsin inhibitor) in severe sepsis: a multicenter randomized controlled study.

Authors:  Dilip R Karnad; Rakesh Bhadade; Pradeep K Verma; Nivedita D Moulick; Mradul K Daga; Neelima D Chafekar; Shivakumar Iyer
Journal:  Intensive Care Med       Date:  2014-04-16       Impact factor: 17.440

10.  Urinary Trypsin Inhibitor Ameliorates Seawater Immersion-Induced Intestinal Mucosa Injury via Antioxidation, Modulation of NF-κB Activity, and Its Related Cytokines in Rats with Open Abdominal Injury.

Authors:  Xing Jian Zhang; Ya Li Wang; Song Zhou; Xiaojun Xue; Qiang Liu; Wen Hua Zhang; Jun Zheng
Journal:  Gastroenterol Res Pract       Date:  2014-08-21       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.